Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 401

1.

Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I.

Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ.

Am J Trop Med Hyg. 2006 Sep;75(3):402-15.

2.

[New use of primaquine for malaria].

Oliver M, Simon F, de Monbrison F, Beavogui AH, Pradines B, Ragot C, Moalic JL, Rapp C, Picot S.

Med Mal Infect. 2008 Apr;38(4):169-79. doi: 10.1016/j.medmal.2008.01.011. Review. French.

PMID:
18395381
3.

Primaquine for prevention of malaria in travelers.

Baird JK, Fryauff DJ, Hoffman SL.

Clin Infect Dis. 2003 Dec 15;37(12):1659-67.

4.

Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future.

Shanks GD, Kain KC, Keystone JS.

Clin Infect Dis. 2001 Aug 1;33(3):381-5. Review.

5.

Malaria surveillance--United States, 2009.

Mali S, Tan KR, Arguin PM; Division of Parasitic Diseases and Malaria, Center for Global Health.; Centers for Disease Control and Prevention..

MMWR Surveill Summ. 2011 Apr 22;60(3):1-15.

6.

Primaquine therapy for malaria.

Baird JK, Hoffman SL.

Clin Infect Dis. 2004 Nov 1;39(9):1336-45. Review.

7.

Prophylaxis for malaria. Helping world travelers come home healthy.

Amin NM.

Postgrad Med. 1992 Sep 1;92(3):161-8. Review.

PMID:
1518752
9.

Plasmodium vivax infections in U.S. Army troops: failure of primaquine to prevent relapse in studies from Somalia.

Smoak BL, DeFraites RF, Magill AJ, Kain KC, Wellde BT.

Am J Trop Med Hyg. 1997 Feb;56(2):231-4.

PMID:
9080885
10.

Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia.

Baird JK, Lacy MD, Basri H, Barcus MJ, Maguire JD, Bangs MJ, Gramzinski R, Sismadi P, Krisin, Ling J, Wiady I, Kusumaningsih M, Jones TR, Fryauff DJ, Hoffman SL; United States Naval Medical Research Unit 2 Clinical Trials Team..

Clin Infect Dis. 2001 Dec 15;33(12):1990-7.

11.

Compliance with 14-day primaquine therapy for radical cure of vivax malaria--a randomized placebo-controlled trial comparing unsupervised with supervised treatment.

Leslie T, Rab MA, Ahmadzai H, Durrani N, Fayaz M, Kolaczinski J, Rowland M.

Trans R Soc Trop Med Hyg. 2004 Mar;98(3):168-73.

PMID:
15024927
12.
13.
14.

Safety and tolerability of elubaquine (bulaquine, CDRI 80/53) for treatment of Plasmidium vivax malaria in Thailand.

Krudsood S, Wilairatana P, Tangpukdee N, Chalermrut K, Srivilairit S, Thanachartwet V, Muangnoicharoen S, Luplertlop N, Brittenham GM, Looareesuwan S.

Korean J Parasitol. 2006 Sep;44(3):221-8.

15.

Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand.

Buchachart K, Krudsood S, Singhasivanon P, Treeprasertsuk S, Phophak N, Srivilairit S, Chalermrut K, Rattanapong Y, Supeeranuntha L, Wilairatana P, Brittenham G, Looareesuwan S.

Southeast Asian J Trop Med Public Health. 2001 Dec;32(4):720-6.

PMID:
12041544
17.

Adequate primaquine for vivax malaria.

Kitchener S, Nasveld P, Bennett S, Torresi J.

J Travel Med. 2005 May-Jun;12(3):133-5.

18.

Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity. A randomized, double-blind, placebo-controlled trial.

Soto J, Toledo J, Rodriquez M, Sanchez J, Herrera R, Padilla J, Berman J.

Ann Intern Med. 1998 Aug 1;129(3):241-4.

PMID:
9696733
19.

Compliance to recommendations for the management of curative treatment of Plasmodium vivax/ovale infections.

Faucher JF, Bellanger AP, Shaniya N, Hustache-Mathieu L, Hoen B, Chirouze C.

Med Mal Infect. 2014 Aug;44(8):387-9. doi: 10.1016/j.medmal.2014.06.006.

PMID:
25015307
20.

The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar.

Myat-Phone-Kyaw, Myint-Oo, Aung-Naing, Aye-Lwin-Htwe.

Southeast Asian J Trop Med Public Health. 1994 Dec;25(4):710-3.

PMID:
7667719
Items per page

Supplemental Content

Support Center